Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

• Main Authors: Gebremedhin Beedemariam Gebretekle (Author), Atalay Mulu Fentie (Author), Girma Tekle Gebremariam (Author), Eskinder Eshetu Ali (Author), Daniel Asfaw Erku (Author), Tinsae Alemayehu (Author), Workeabeba Abebe (Author), Beate Sander (Author)
• Format: Book
• Published: BMC, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Invasive candidiasis and/or candidemia (IC/C) is a common fungal infection leading to significant health and economic losses worldwide. Caspofungin was shown to be more effective than fluconazole in treating inpatients with IC/C. However, cost-effectiveness of caspofungin for tre...